Cowan Elvia
Insider CIK 1960048 · PCVX SVP, Finance & CAO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-10-05 | 2026-10-07 | 19,000 | — | $0 | 74,068 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-10-05 | 2026-10-07 | 19,000 | $86.74 | $1.65M | 27,860 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-10-05 | 2026-10-07 | 19,000 | $25.92 | $492.5K | 46,860 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 1,327 | $60.36 | $80.1K | 27,860 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-08 | 2026-09-09 | 1,327 | $60.36 | $80.1K | 27,860 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 326 | $61.58 | $20.1K | 29,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-09-02 | 2026-09-02 | 326 | $61.58 | $20.1K | 29,187 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 243 | $60.74 | $14.8K | 29,513 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-08-31 | 2026-09-02 | 243 | $60.74 | $14.8K | 29,513 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-04-07 | 2026-04-08 | 3,000 | — | $0 | 93,068 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-04-07 | 2026-04-08 | 3,000 | $25.92 | $77.8K | 31,975 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-04-07 | 2026-04-08 | 3,000 | $60.00 | $180.0K | 28,975 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-03-17 | 2026-03-18 | 1,487 | $55.39 | $82.4K | 29,380 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-03-17 | 2026-03-18 | 405 | $56.26 | $22.8K | 28,975 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-03-11 | 2026-03-11 | 2,500 | — | $0 | 96,068 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-03-11 | 2026-03-11 | 2,500 | $25.92 | $64.8K | 33,367 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2026-03-11 | 2026-03-11 | 2,500 | $58.59 | $146.5K | 30,867 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-09 | 2026-03-11 | 495 | $59.32 | $29.4K | 30,867 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-03-02 | 2026-03-02 | 326 | $61.98 | $20.2K | 31,362 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2026-02-28 | 2026-03-02 | 243 | $61.98 | $15.1K | 31,688 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2026-02-26 | 2026-03-02 | 7,716 | — | $0 | 98,568 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2026-02-26 | 2026-03-02 | 17,855 | — | $0 | 17,855 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2026-02-26 | 2026-03-02 | 7,716 | $25.92 | $200.0K | 31,931 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2026-02-26 | 2026-03-02 | 10,681 | — | $0 | 24,215 | SEC↗ |
| PCVX Vaxcyte, Inc. | G Gift | 2025-12-23 | 2025-12-29 | 1,000 | — | $0 | 13,534 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-12-23 | 2025-12-29 | 4,907 | $47.90 | $235.0K | 21,250 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2025-12-23 | 2025-12-29 | 6,716 | $47.94 | $322.0K | 14,534 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-08 | 2025-09-10 | 482 | $32.41 | $15.6K | 26,156 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-09-07 | 2025-08-29 | 2,810 | — | $0 | 27,205 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 242 | $31.56 | $7.6K | 26,963 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-09-02 | 2025-09-04 | 325 | $31.56 | $10.3K | 26,638 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-08-29 | 2025-08-29 | 9,743 | — | $0 | 9,743 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-03-03 | 2025-03-03 | 325 | $72.10 | $23.4K | 24,106 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2025-02-28 | 2025-03-03 | 242 | $73.02 | $17.7K | 24,431 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2025-02-27 | 2025-03-03 | 17,961 | — | $0 | 17,961 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2025-02-27 | 2025-03-03 | 5,379 | — | $0 | 24,673 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-12-16 | 2024-12-18 | 7,716 | — | $0 | 106,284 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-12-16 | 2024-12-18 | 7,716 | $25.92 | $200.0K | 19,294 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-11-07 | 2024-11-08 | 11,900 | — | $0 | 11,900 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 5,000 | — | $0 | 114,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-09-03 | 2024-09-05 | 1,145 | $110.15 | $126.1K | 11,578 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 5,000 | $107.67 | $538.4K | 12,723 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 5,000 | $25.92 | $129.6K | 17,723 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-07-16 | 2024-07-17 | 5,000 | — | $0 | 119,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-16 | 2024-07-17 | 5,000 | $85.00 | $425.0K | 12,723 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-07-16 | 2024-07-17 | 5,000 | $25.92 | $129.6K | 17,723 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-07-08 | 2024-07-09 | 5,000 | — | $0 | 124,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-07-08 | 2024-07-09 | 5,000 | $80.00 | $400.0K | 12,723 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-07-08 | 2024-07-09 | 5,000 | $25.92 | $129.6K | 17,723 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2024-03-02 | 2024-03-04 | 324 | $71.55 | $23.2K | 12,156 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-04 | 11,000 | — | $0 | 129,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 4,455 | $73.69 | $328.3K | 17,381 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 2,322 | $73.08 | $169.7K | 21,836 | SEC↗ |
| PCVX Vaxcyte, Inc. | M Exercise | 2024-03-01 | 2024-03-04 | 11,000 | $25.92 | $285.1K | 24,158 | SEC↗ |
| PCVX Vaxcyte, Inc. | S Sale | 2024-03-01 | 2024-03-04 | 4,901 | $74.90 | $367.1K | 12,480 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2024-02-29 | 2024-03-04 | 5,400 | — | $0 | 13,158 | SEC↗ |
| PCVX Vaxcyte, Inc. | F Tax w/h | 2023-09-05 | 2023-09-06 | 627 | $51.00 | $32.0K | 7,301 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 43,500 | — | $0 | 43,500 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award | 2023-03-01 | 2023-03-03 | 7,250 | — | $0 | 7,250 | SEC↗ |